Marijuana firm MedMen, top execs face $20 million suit for allegedly breaching duties, enriching selves

Cannabis industry retail giant MedMen Enterprises and its top executives face a $19.8 million lawsuit by an early investor group who charge that senior execs enriched themselves at the expense of shareholders and breached their fiduciary duties.